BMJ policy on trials of drugs and devices: advice to authorsBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b146 (Published 11 February 2009) Cite this as: BMJ 2009;338:b146
We welcome submission of any trial of a drug or device that asks an original research question that will sufficiently aid doctors’ decisions. This is most likely to be a trial that directly compares a new drug or device (or new regimen or indication) with the best current treatment(s) using clinically valid doses or administration of both study and comparator interventions. Placebo controlled trials often have much more limited relevance …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial